REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanomed D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanomed D.O.O. Beograd Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sanomed D.O.O. Beograd is a company in Serbia, with a head office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Sanomed D.O.O. Beograd was incorporated on August 17, 2009. It currently has a total number of 11 (2023) employees. From the latest financial highlights, Sanomed D.O.O. Beograd reported a net sales revenue increase of 20.48% in 2023. Its’ total assets recorded a growth of 18.36%. The net profit margin of Sanomed D.O.O. Beograd decreased by 2.59% in 2023.

Headquarters
Vojislava Ilica 69
Belgrade; Belgrade; Postal Code: www.sanomed.rs

Contact Details: Purchase the Sanomed D.O.O. Beograd report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Sanomed D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Sanomed D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Sanomed D.O.O. Beograd report to view the information.
Incorporation Date:
August 17, 2009
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sanomed D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
20.48%
Total operating revenue
20.75%
Operating profit (EBIT)
7.55%
EBITDA
7.72%
Net Profit (Loss) for the Period
4.83%
Total assets
18.36%
Total equity
31.85%
Operating Profit Margin (ROS)
-2.06%
Net Profit Margin
-2.59%
Return on Equity (ROE)
-6.86%
Debt to Equity Ratio
-4.57%
Quick Ratio
0.4%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?